Status:
COMPLETED
Modelling in the Quantitative Analysis of Brain PET Scans in Patients With Alzheimer's Disease
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Patients With Alzheimer's Disease
Eligibility:
All Genders
18+ years
Brief Summary
PET/CT scans with 18F-FDG can be carried out for the detection of neurodegenerative diseases with hypometabolisms characteristic of the pathologies sought. The diagnosis is given by the clinician afte...
Detailed Description
PET/CT scans with 18F-FDG can be carried out for the detection of neurodegenerative diseases with hypometabolisms characteristic of the pathologies sought. The diagnosis is given by the clinician afte...
Eligibility Criteria
Inclusion
- Brain PET/CT scans at 18F-FDG of patients with Alzheimer's disease carried out in the nuclear medicine department of the Nancy-Brabois University Hospital since December 2017 on digital PET devices.
Exclusion
- Patients who have expressed their opposition to the use of their data (poster in the service).
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04718207
Start Date
February 1 2021
End Date
February 1 2022
Last Update
August 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nuclear medicine department CHRU de NANCY Brabois
Vandœuvre-lès-Nancy, France, 54511